Abstract
One of the goals of personalised medicine (PM) is to use the ever-growing understanding of biology to provide a higher level of precision in disease prevention and patient care. PM strategies include the use of decision-making processes based on biomarker-driven approaches. Genes, gene expression products (i.e. transcripts and proteins) and metabolites are the main biomarker families. Given this molecular diversity of biomarkers, the increase in high-throughput omics technologies offers an amazing opportunity to capture the whole picture of biological systems in a hypothesis-free and unbiased model. This chapter examines as the high-throughput era in omics is progressing and as genomics and other omics will be effective in disentangling the aetiology and progression of the diseases.
Original language | English |
---|---|
Title of host publication | Personalised Health Care : Fostering Precision Medicine Advancements for Gaining Population Health Impact |
Editors | S. Boccia, R. Adany, P. Villari, M. C. Cornel, C. de Vito, R. Pastorino |
Place of Publication | Springer |
Publisher | [uitgever onbekend] |
Pages | 9-32 |
Number of pages | 24 |
ISBN (Print) | 9783030523985 |
DOIs | |
Publication status | Published - 2021 |
Publication series
Series | SpringerBriefs in Public Health |
---|
Bibliographical note
Publisher Copyright:© 2021, The Editor(s) and Author(s), under exclusive license to Springer Nature Switzerland AG.
Research programs
- EMC OR-01